Since the first bispecific antibody (BsAb), a novel class of immunotherapy, received approval from the FDA in 2014, the drug class has developed exponentially, but not without its challenges. Namely, BsAbs present unique and serious toxicities such as cytokine release syndrome and immune effector cell–associated neurotoxicity syndrome. With a high proportion of patients receiving treatment in community cancer centers, these clinicians are tasked with understanding BsAb pharmacology and preparing for the logistical demands that accompany this form of treatment. Doing so effectively requires strong collaboration across the multidisciplinary cancer care team.
To demonstrate successful examples of such collaboration, ACCC launched Project ECHO®: Best Practices for Administering Bispecific Antibodies in a Community Practice as a resource for multidisciplinary oncology teams as they prepare to implement BsAbs in their cancer programs. Building on the 2 previous iterations of Project ECHO®️, Tele-mentoring to Manage Immune-related Adverse Events in Patients Receiving Cancer Immunotherapies and Evolving Role of Bispecific Antibodies as Cancer Therapy, this initiative guides community oncologists on evidence-based practices for the use of BsAbs in solid and hematologic malignancies through a series of 3 webinars.
Earn up to 3.0 CME/CNE/CPE credits upon completion of ACCC’s 3-part webinar series designed to support multidisciplinary oncology teams in the use of BsAbs for cancer treatment.
Session 1: Best Practices for BsAb Use in Lung Cancer and Other Solid Tumors
Session 2: Overcoming Operational Challenges in Community Settings
Session 3: Referral Workflows and Care Coordination for BsAb Treatment
After completing this educational activity, learners will be able to:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Physicians' Education Resource®, LLC and the Association of Community Cancer Centers (ACCC). Physicians' Education Resource®, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. These live activities are each approved for 1.0 contact hour (0.10 CEU).
Physicians' Education Resource®, LLC designates each live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours per session.
PTCE designates these knowledge-based activities for a maximum of 1.0 hours each. Credit will be provided to NABP CPE Monitor within 60 days after activity completion.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Physicians' Education Resource®, LLC and the Association of Community Cancer Centers (ACCC). Physicians' Education Resource®, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. These live activities are each approved for 1.0 contact hour (0.10 CEU).
Physicians' Education Resource®, LLC designates each live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours per session.
PTCE designates these knowledge-based activities for a maximum of 1.0 hours each. Credit will be provided to NABP CPE Monitor within 60 days after activity completion.